Stay updated with breaking news from Stevenage Bioscience Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technolog...
)
Laverock Therapeutics, which is growing fast from its base at Stevenage Bioscience Catalyst, has unveiled Ali Elsley as Finance Director and revealed significant expansion of its team.
Labour’s science secretary, Peter Kyle, promised to “get the planning system sorted” to tackle a lab space shortage on a visit to Stevenage.
As we celebrate the beginning of a new year, the Comet takes a look back at the year that was with a round up of 2023.
The company aims to become a global leader in precision oncology by redefining Synthetic Lethality to treat large, currently unserved patient populationsLead program targets Alternative Lengthening of Telomeres (ALT)